Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

December 21, 2016

Primary Completion Date

January 14, 2019

Study Completion Date

April 1, 2019

Conditions
Systemic Sclerosis
Interventions
DRUG

SAR156597

Pharmaceutical form: Solution Route of administration: Subcutaneous

DRUG

Placebo

Pharmaceutical form: Solution Route of administration: Subcutaneous

Trial Locations (44)

3000

Investigational Site Number 0560002, Leuven

9000

Investigational Site Number 0560001, Ghent

10043

Investigational Site Number 3800006, Orbassano

10117

Investigational Site Number 2760001, Berlin

13419

Investigational Site Number 2330001, Tallinn

16132

Investigational Site Number 3800004, Genova

20007

Investigational Site Number 8400005, Washington D.C.

20122

Investigational Site Number 3800001, Milan

Investigational Site Number 3800005, Milan

31000

Investigational Site Number 4840001, Chihuahua City

34295

Investigational Site Number 2500003, Montpellier

44160

Investigational Site Number 4840005, Guadalajara

44195

Investigational Site Number 8400002, Cleveland

44690

Investigational Site Number 4840002, Guadalajara

50937

Investigational Site Number 2760002, Cologne

61231

Investigational Site Number 2760003, Bad Nauheim

64460

Investigational Site Number 4840003, Monterrey

67098

Investigational Site Number 2500002, Strasbourg

75014

Investigational Site Number 2500004, Paris

77030

Investigational Site Number 8400007, Houston

89081

Investigational Site Number 2760004, Ulm

94143

Investigational Site Number 8400006, San Francisco

115404

Investigational Site Number 6430005, Moscow

115522

Investigational Site Number 6430001, Moscow

125284

Investigational Site Number 6430004, Moscow

400006

Investigational Site Number 6420001, Cluj-Napoca

450005

Investigational Site Number 6430003, Ufa

540142

Investigational Site Number 6420002, Târgu Mureş

650000

Investigational Site Number 6430002, Kemerovo

C1015ABO

Investigational Site Number 0320003, Buenos Aires

C1181ACH

Investigational Site Number 0320002, Caba

C1280AEB

Investigational Site Number 0320005, Capital Federal

T4000AXL

Investigational Site Number 0320001, San Miguel de Tucumán

61-397

Investigational Site Number 6160001, Poznan

02-691

Investigational Site Number 6160002, Warsaw

52-416

Investigational Site Number 6160003, Wroclaw

011172

Investigational Site Number 6420003, Bucharest

Investigational Site Number 6420004, Bucharest

020475

Investigational Site Number 6420005, Bucharest

02125

Investigational Site Number 8040001, Kyiv

03151

Investigational Site Number 8040002, Kyiv

04050

Investigational Site Number 8040004, Kyiv

04070

Investigational Site Number 8040003, Kyiv

Unknown

Investigational Site Number 8260001, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY